BRIEF published on 10/17/2025 at 16:17, 1 year ago The Vanguard Group Discloses Position in JTC plc Form 8.3 The Vanguard Group Takeover Code Securities Interests JTC Plc
BRIEF published on 10/17/2025 at 16:15, 1 year ago The Vanguard Group Files Disclosure on Mural Oncology Stake Ordinary Shares Irish Takeover Panel Vanguard Group Stake Disclosure Mural Oncology
PRESS RELEASE published on 10/17/2025 at 16:15, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.57% interest in Qualcomm Incorporated. Dealings include purchase and sale of relevant securities Financial Dealings The Vanguard Group Stock Market Interests Disclosure Qualcomm Incorporated
BRIEF published on 10/17/2025 at 16:14, 1 year ago The Vanguard Group Discloses Position in Greencore Group plc Takeover Code Vanguard Group Equity Disclosure Greencore Group Share Purchase/Sale
PRESS RELEASE published on 10/17/2025 at 16:13, 1 year ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.54% ownership in American Axle & Manufacturing Holdings, Inc. through relevant securities. Additional disclosure related to Dowlais Group plc made Relevant Securities The Vanguard Group Ownership Disclosure Dowlais Group Plc American Axle & Manufacturing Holdings
BRIEF published on 10/17/2025 at 16:13, 1 year ago The Vanguard Group Discloses Position in Spire Healthcare Securities Healthcare Sector Vanguard Group Spire Healthcare Investment Disclosure
PRESS RELEASE published on 10/17/2025 at 16:12, 1 year ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% stake in JTC plc per Form 8.3 filing under the Takeover Code on 17-Oct-2025 The Vanguard Group, Inc. Form 8.3 Takeover Code Stake Disclosure JTC Plc
BRIEF published on 10/17/2025 at 16:11, 1 year ago The Vanguard Group Discloses Stake in Alphawave IP Group Takeover Code Vanguard Group Stake Disclosure Investment Position Alphawave IP
PRESS RELEASE published on 10/17/2025 at 16:10, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% stake in Mural Oncology plc as of 16 Oct 2025 under Rule 8.3 to the Irish Takeover Panel The Vanguard Group, Inc. Disclosure Irish Takeover Panel Rule 8.3 Mural Oncology Plc
BRIEF published on 10/17/2025 at 16:10, 1 year ago Vanguard Discloses Key Positions in Dowlais Group Form 8.3 Takeover Code Securities Disclosure Vanguard Group Dowlais Group
Published on 11/10/2026 at 23:00, 14 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 14 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 14 minutes ago Condor Agrees to Short Extension of Lucero Closing Payment with ELEMENT79 and Provides Huiñac Punta Drill Program Update
Published on 11/10/2026 at 22:30, 44 minutes ago Amdocs Announces First Quarter Fiscal 2027 Investor Conference Schedule
Published on 11/10/2026 at 22:00, 1 hour 14 minutes ago Worksport Q3 Net Sales Increase 44.2% Year-Over-Year to a Record $7.2 Million Worksport (NASDAQ: WKSP) Q3 Revenue Rises 44% to Record $7.23 Million as Net Loss Narrows 28%
Published on 11/10/2026 at 18:54, 4 hours 19 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 4 hours 28 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 4 hours 43 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 17:31, 5 hours 42 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 9 hours 13 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 12 hours 11 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 16 hours 14 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 4 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
